Status:
RECRUITING
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Gaucher Disease
Cerebroside Lipidosis Syndrome
Eligibility:
All Genders
Brief Summary
The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatme...
Eligibility Criteria
Inclusion
- ICGG Gaucher Registry
- All patients with a confirmed diagnosis of Gaucher disease are eligible for inclusion in the Registry. Confirmed diagnosis is defined as a documented β-glucocerebrosidase deficiency and/or mutation in the β-glucocerebrosidase gene.
- For all patients, appropriate patient authorization will be obtained.
- Gaucher Pregnancy Sub-registry:
- be enrolled in the ICGG Gaucher Registry.
- be pregnant, or have been pregnant with appropriate medical documentation available.
- provide a signed informed consent and authorization form(s) to participate in the Sub-Registry prior to any Sub-Registry-related data collection being performed.
Exclusion
- \- No exclusion criteria for participation in the ICGG Gaucher Registry and Sub-registry.
Key Trial Info
Start Date :
April 1 1991
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2034
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT00358943
Start Date
April 1 1991
End Date
January 31 2034
Last Update
January 6 2026
Active Locations (318)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix Children's Hospital- Site Number : 840003
Phoenix, Arizona, United States, 85013
2
University of Arizona- Site Number : 840015
Tucson, Arizona, United States, 85724
3
Arkansas Childrens Hospital- Site Number : 840109
Little Rock, Arkansas, United States, 72202
4
University of Arkansas for Medical Sciences- Site Number : 840113
Little Rock, Arkansas, United States, 72205